“Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity”. 2025. Journal of Carcinogenesis 24 (8s): 343-51. https://doi.org/10.64149/J.Carcinog.24.8s.343-351.